Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy.
Palmieri L, Vanacore N, Donfrancesco C, Lo Noce C, Canevelli M, Punzo O, Raparelli V, Pezzotti P, Riccardo F, Bella A, Fabiani M, D'Ancona FP, Vaianella L, Tiple D, Colaizzo E, Palmer K, Rezza G, Piccioli A, Brusaferro S, Onder G; Italian National Institute of Health COVID-19 Mortality Group. Palmieri L, et al. Among authors: fabiani m. J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1796-1800. doi: 10.1093/gerona/glaa146. J Gerontol A Biol Sci Med Sci. 2020. PMID: 32506122 Free PMC article.
Comorbidity status of deceased COVID-19 in-patients in Italy.
Vetrano DL, Tazzeo C, Palmieri L, Marengoni A, Zucchelli A, Lo Noce C, Onder G; Italian National Institute of Health Covid-Mortality Group. Vetrano DL, et al. Aging Clin Exp Res. 2021 Aug;33(8):2361-2365. doi: 10.1007/s40520-021-01914-y. Epub 2021 Jun 24. Aging Clin Exp Res. 2021. PMID: 34169447 Free PMC article.
Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study.
Massari M, Spila-Alegiani S, Fabiani M, Belleudi V, Trifirò G, Kirchmayer U, Poggi FR, Mancuso P, Menniti-Ippolito F, Gini R, Bartolini C, Leoni O, Ercolanoni M, Da-Re F, Guzzinati S, Luxi N, Riccardo F, Giorgi-Rossi P. Massari M, et al. Among authors: fabiani m. Vaccines (Basel). 2021 Jul 1;9(7):716. doi: 10.3390/vaccines9070716. Vaccines (Basel). 2021. PMID: 34358133 Free PMC article.
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021.
Fabiani M, Puopolo M, Filia A, Sacco C, Mateo-Urdiales A, Spila Alegiani S, Del Manso M, D'Ancona F, Vescio F, Bressi M, Petrone D, Spuri M, Rota MC, Massari M, Da Cas R, Morciano C, Stefanelli P, Bella A, Tallon M, Proietti V, Siddu A, Battilomo S, Palamara AT, Popoli P, Brusaferro S, Rezza G, Riccardo F, Menniti Ippolito F, Pezzotti P. Fabiani M, et al. Expert Rev Vaccines. 2022 Jul;21(7):975-982. doi: 10.1080/14760584.2022.2064280. Epub 2022 Apr 15. Expert Rev Vaccines. 2022. PMID: 35389748 Free PMC article.
COVID-19 vaccines coverage and effectiveness against SARS-CoV-2 infection among residents in the largest Health Authority of Lazio region (Italy): a population-based cohort study.
Fano V, Coviello E, Consonni D, Agresta A, Orsini N, Crielesi A, Miglietta AS, Pasqua C, Vairo F, Vivaldi F, De Angelis G, Colaiocco G, Fabiani M. Fano V, et al. Among authors: fabiani m. Expert Rev Vaccines. 2022 Aug;21(8):1147-1157. doi: 10.1080/14760584.2022.2080057. Epub 2022 Jun 1. Expert Rev Vaccines. 2022. PMID: 35584901
Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022).
Petrone D, Mateo-Urdiales A, Sacco C, Riccardo F, Bella A, Ambrosio L, Lo Presti A, Di Martino A, Ceccarelli E, Del Manso M, Fabiani M, Stefanelli P, Pezzotti P, Palamara A; Italian Integrated Surveillance of COVID-19. Petrone D, et al. Among authors: fabiani m. Int J Infect Dis. 2023 Apr;129:135-141. doi: 10.1016/j.ijid.2023.01.027. Epub 2023 Jan 26. Int J Infect Dis. 2023. PMID: 36708869 Free PMC article.
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study.
Mateo-Urdiales A, Sacco C, Fotakis EA, Del Manso M, Bella A, Riccardo F, Bressi M, Rota MC, Petrone D, Siddu A, Fedele G, Stefanelli P, Palamara AT, Brusaferro S, Rezza G, Pezzotti P, Fabiani M. Mateo-Urdiales A, et al. Among authors: fabiani m. Lancet Infect Dis. 2023 Dec;23(12):1349-1359. doi: 10.1016/S1473-3099(23)00374-2. Epub 2023 Jul 18. Lancet Infect Dis. 2023. PMID: 37478877
Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality.
Marziano V, Guzzetta G, Menegale F, Sacco C, Petrone D, Mateo Urdiales A, Del Manso M, Bella A, Fabiani M, Vescio MF, Riccardo F, Poletti P, Manica M, Zardini A, d'Andrea V, Trentini F, Stefanelli P, Rezza G, Palamara AT, Brusaferro S, Ajelli M, Pezzotti P, Merler S. Marziano V, et al. Among authors: fabiani m. Influenza Other Respir Viruses. 2023 Aug 16;17(8):e13181. doi: 10.1111/irv.13181. eCollection 2023 Aug. Influenza Other Respir Viruses. 2023. PMID: 37599801 Free PMC article.
428 results